Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$4.81 - $5.78 $3,352 - $4,028
-697 Reduced 53.95%
595 $3,000
Q1 2024

Apr 18, 2024

SELL
$4.93 - $9.31 $19,641 - $37,091
-3,984 Reduced 75.51%
1,292 $6,000
Q4 2023

Jan 25, 2024

SELL
$7.13 - $9.49 $680,415 - $905,630
-95,430 Reduced 94.76%
5,276 $47,000
Q3 2023

Oct 27, 2023

BUY
$7.77 - $12.27 $782,485 - $1.24 Million
100,706 New
100,706 $782,000
Q2 2023

Jul 18, 2023

BUY
$8.96 - $11.69 $135,582 - $176,893
15,132 Added 13044.83%
15,248 $147,000
Q1 2023

Apr 13, 2023

SELL
$5.94 - $11.27 $43,552 - $82,631
-7,332 Reduced 98.44%
116 $1,000
Q4 2022

Jan 23, 2023

SELL
$4.11 - $8.14 $669 - $1,326
-163 Reduced 2.14%
7,448 $0
Q3 2022

Oct 26, 2022

BUY
$6.66 - $12.39 $50,689 - $94,300
7,611 New
7,611 $57,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.